European Journal of Cardiovascular Medicine

Background: Hemodialysis is a therapeutic intervention utilised for individuals with end-stage renal disease (ESRD), which has been identified as a contributing factor to cognitive impairment among patients. Materials and Methods: The present cross-sectional investigation was carried out on a cohort of one hundred patients diagnosed with end-stage renal disease (ESRD) who sought medical attention at SAIMS Hospital during the period spanning from April 2021 to October 2022, following the approval of the institutional ethics committee. The participants were selected through the use of convenience sampling. Results: The study involved the examination of a total of 160 patients, of which 67 (42%) were found to exhibit cognitive impairment. The findings indicate that solely age and a prior occurrence of stroke exhibit a statistically significant association with this particular cognitive impairment. Specifically, the likelihood of experiencing cognitive impairment rises in tandem with advancing age, while a history of stroke is linked to a six-fold increase in the risk of developing this condition. Conclusion: The present investigation revealed that hemodialysis was associated with a considerable incidence of cognitive impairment. The presence of advanced age and a prior history of stroke are identified as potential risk factors for cognitive impairment among individuals undergoing hemodialysis treatment for chronic kidney failure.